ViralClear to Host Conference Call on September 22, 2020, to Discuss Phase 2 Human Trial of AntiViral Merimepodib Oral Solution for Treatment of COVID-19 September 9, 2020
BioSig to Host Conference Call on September 15, 2020 to Discuss Unblinding of PURE EP Human Data September 2, 2020
Infectious Diseases Expert Prof. Angus Dalgleish Joins ViralClear’s Scientific Advisory Board August 6, 2020
BioSig Technologies to Present at the Proactive Investors One2One Virtual Event on August 4, 2020 July 30, 2020
